PHX 11.9% 4.7¢ pharmx technologies limited

Ann: Annual Report to shareholders, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,236 Posts.
    lightbulb Created with Sketch. 468
    A positive report, particularly with some upbeat commentary from the Chairman and MD.

    Highlights for me included:
    - After tax profit of $251k in a year of transition
    - Corum Clear is fully developed and ready to be launched to the market
    - Other products developed (Safeguard and ARCScript) are contributing to revenue with take-up of 30% of customers. To me that says there are still potential targets for an upsell
    - Costs decreased over the year, Chairman suggests these could reduce by another 15% this year. This is roughly $2m off the current cost base, which post development of Corum Clear is understandable.
    - Targeting revenue growth of 10%, which combined with the cost savings, would see revenues of $14m and costs of $10m, so a potential $4m in net profit after tax without taking into account any one-offs.
    - Mergers and acqusitions are still being reviewed.
    - Cash at the end of this quarter is expected to be $6.7m

    For the first time in while, things are looking up. A good half year result and an interim dividends might even be on the cards.
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
(20min delay)
Last
4.7¢
Change
0.005(11.9%)
Mkt cap ! $28.12M
Open High Low Value Volume
4.2¢ 4.8¢ 4.2¢ $31.55K 693.9K

Buyers (Bids)

No. Vol. Price($)
1 74051 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 77252 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PHX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.